Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Danaher Corp (DHR)

Danaher Corp (DHR)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 165,688,256
  • Shares Outstanding, K 713,067
  • Annual Sales, $ 22,284 M
  • Annual Income, $ 3,646 M
  • 60-Month Beta 0.66
  • Price/Sales 7.36
  • Price/Cash Flow 23.68
  • Price/Book 4.47
Trade DHR with:

Options Overview

Details
  • Implied Volatility 23.02%
  • Historical Volatility 20.87%
  • IV Percentile 1%
  • IV Rank 1.19%
  • IV High 41.94% on 04/13/20
  • IV Low 22.79% on 08/21/20
  • Put/Call Vol Ratio 1.71
  • Today's Volume 1,012
  • Volume Avg (30-Day) 1,511
  • Put/Call OI Ratio 0.45
  • Today's Open Interest 33,516
  • Open Int (30-Day) 30,424

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 12 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/21
See More
  • Average Estimate 1.67
  • Number of Estimates 8
  • High Estimate 1.74
  • Low Estimate 1.59
  • Prior Year 1.05
  • Growth Rate Est. (year over year) +59.05%

Price Performance

See More
Period Period Low Period High Performance
1-Month
211.22 +10.01%
on 03/10/21
232.37 unch
on 04/09/21
+16.02 (+7.41%)
since 03/09/21
3-Month
211.22 +10.01%
on 03/10/21
248.86 -6.63%
on 02/16/21
-11.13 (-4.57%)
since 01/08/21
52-Week
143.01 +62.48%
on 04/13/20
248.86 -6.63%
on 02/16/21
+86.63 (+59.45%)
since 04/09/20

Most Recent Stories

More News
Crane (CR) Share Price Increases 21% YTD: What's Driving It?

Crane (CR), with a 21% increase in shares year to date, gains from solid product offering, improving market demand and growth investments. Also, acquired assets are advantageous.

ITT : 91.35 (+0.22%)
DHR : 232.36 (+1.05%)
CSL : 171.63 (+1.10%)
CR : 95.26 (+1.50%)
Raven (RAVN) Buys Jaybridge Robotics' Intellectual Property

Raven's (RAVN) purchase of the intellectual property of Jaybridge Robotics enhances its technology portfolio meant for use in the agriculture industry.

HON : 226.98 (+3.24%)
RAVN : 38.40 (-0.47%)
DHR : 232.36 (+1.05%)
GFF : 27.58 (+0.25%)
General Electric (GE) Units Secure Turbines & Services Contract

General Electric's (GE) Renewable Energy to deliver wind turbines to North Central Wind Energy Facilities. GE Power will provide maintenance services at a Bangladesh-based combined cycle power plant.

GE : 13.60 (+1.12%)
DHR : 232.36 (+1.05%)
CR : 95.26 (+1.50%)
GFF : 27.58 (+0.25%)
HC2 Holdings (HCHC) to Sell Insurance Segment & Solidify Portfolio

HC2 Holdings' (HCHC) divestment of the insurance business will help it ensure financial flexibility and strengthen the balance sheet as well as allow focus on other key businesses.

MMM : 198.00 (+1.16%)
GE : 13.60 (+1.12%)
DHR : 232.36 (+1.05%)
HCHC : 4.17 (+4.51%)
Danaher Schedules First Quarter 2021 Earnings Conference Call

, /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that it will webcast its quarterly earnings conference call for the first quarter 2021 on beginning at and lasting approximately 1 hour.

DHR : 232.36 (+1.05%)
Beckman Coulter's SARS-CoV-2 IgG II antibody test receives Emergency Use Authorization from the FDA

, /PRNewswire/ -- Beckman Coulter, a clinical diagnostics leader, today announced that its  antibody assay received U.S. Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration....

DHR : 232.36 (+1.05%)
Crane (CR) to Gain From End-Market Strength, Inorganic Moves

Crane (CR) to gain from end-market strength, acquisitions, solid product offerings and efficient management team. Also, its policy of rewarding shareholders raises the stock's attractiveness.

MMM : 198.00 (+1.16%)
DHR : 232.36 (+1.05%)
CSL : 171.63 (+1.10%)
CR : 95.26 (+1.50%)
Danaher Corp Down 5.4% Since SmarTrend Downtrend Call (DHR)

SmarTrend identified a Downtrend for Danaher Corp (NYSE:DHR) on February 22nd, 2021 at $228.35. In approximately 3 weeks, Danaher Corp has returned 5.43% as of today's recent price of $215.95.

DHR : 232.36 (+1.05%)
Beckman Coulter Offers $4/High-throughput Antigen Test to Support U.S. Government Initiative to Expand COVID-19 Testing

, /PRNewswire/ -- Beckman Coulter, a clinical diagnostics leader, today announced their commitment to support the U.S. government's plan to invest more than to expand COVID-19 testing with their high-throughput,...

DHR : 232.36 (+1.05%)
Carlisle (CSL) Displays Bright Prospects Despite Persistent Risks

Carlisle (CSL) to gain from a strong reroofing market, strength in the medical business, acquired assets and shareholder-friendly policies. Weakness in the commercial aerospace business is concerning.

DHR : 232.36 (+1.05%)
CSL : 171.63 (+1.10%)
GFF : 27.58 (+0.25%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Business Summary

Danaher Corporation is a global science and technology innovator committed to helping customers solve complex challenges and improving quality of life around the world. It operates through the following business segments : Test & Measurement, Environmental, Life Sciences & Diagnostics, Dental and Industrial...

See More

Key Turning Points

3rd Resistance Point 236.82
2nd Resistance Point 234.59
1st Resistance Point 233.48
Last Price 232.36
1st Support Level 230.14
2nd Support Level 227.91
3rd Support Level 226.80

See More

52-Week High 248.86
Last Price 232.36
Fibonacci 61.8% 208.43
Fibonacci 50% 195.93
Fibonacci 38.2% 183.44
52-Week Low 143.01

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar